vaayaa Inclusive Education
Healthcare 1 min read

FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose

Jun 17, 2026

The U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergency treatment of opioid overdose.

Read full article on FDA Press Releases →

Source: FDA Press Releases — US Government, Public Domain

More in Healthcare

Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread The Conversation Health · 2 min Autistic children drown at alarming rates - swim lessons and water safety strategies can save their lives The Conversation Health · 2 min FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing FDA Press Releases · 1 min FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol FDA Press Releases · 1 min